Kevin O. Hicks

2.3k total citations
56 papers, 1.7k citations indexed

About

Kevin O. Hicks is a scholar working on Cancer Research, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Kevin O. Hicks has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cancer Research, 23 papers in Molecular Biology and 11 papers in Biomedical Engineering. Recurrent topics in Kevin O. Hicks's work include Cancer, Hypoxia, and Metabolism (39 papers), Glioma Diagnosis and Treatment (9 papers) and Nanoplatforms for cancer theranostics (8 papers). Kevin O. Hicks is often cited by papers focused on Cancer, Hypoxia, and Metabolism (39 papers), Glioma Diagnosis and Treatment (9 papers) and Nanoplatforms for cancer theranostics (8 papers). Kevin O. Hicks collaborates with scholars based in New Zealand, United States and United Kingdom. Kevin O. Hicks's co-authors include William R. Wilson, Frederik B. Pruijn, William A. Denny, Michael P. Hay, Bronwyn G. Siim, Kashyap Patel, Susan M. Pullen, Adam V. Patterson, Yongchuan Gu and Timothy W. Secomb and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Kevin O. Hicks

53 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin O. Hicks New Zealand	25	879	718	429	321	240	56	1.7k
Frederik B. Pruijn New Zealand	25	729 0.8×	791 1.1×	347 0.8×	297 0.9×	182 0.8×	57	1.7k
S. R. McKeown United Kingdom	20	952 1.1×	882 1.2×	317 0.7×	317 1.0×	182 0.8×	26	1.9k
Frédéric Dayan France	10	1.5k 1.7×	1.8k 2.5×	212 0.5×	420 1.3×	105 0.4×	15	2.7k
Bronwyn G. Siim New Zealand	17	766 0.9×	738 1.0×	183 0.4×	276 0.9×	122 0.5×	23	1.4k
Aurelio Lorico United States	30	724 0.8×	1.7k 2.4×	190 0.4×	1.2k 3.7×	86 0.4×	82	2.8k
Gillian Paine-Murrieta United States	16	545 0.6×	1.4k 2.0×	96 0.2×	323 1.0×	79 0.3×	18	2.1k
Cyril Corbet Belgium	28	1.7k 1.9×	2.1k 2.9×	409 1.0×	636 2.0×	80 0.3×	59	3.4k
В Ф Чехун Ukraine	17	717 0.8×	1.2k 1.6×	139 0.3×	503 1.6×	53 0.2×	156	2.0k
Germana Rappa United States	29	644 0.7×	1.6k 2.2×	175 0.4×	1.2k 3.9×	77 0.3×	61	2.6k
Dean C. Singleton New Zealand	14	367 0.4×	1.0k 1.4×	215 0.5×	272 0.8×	102 0.4×	24	1.6k

Countries citing papers authored by Kevin O. Hicks

Since Specialization

Citations

This map shows the geographic impact of Kevin O. Hicks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin O. Hicks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin O. Hicks more than expected).

Fields of papers citing papers by Kevin O. Hicks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin O. Hicks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin O. Hicks. The network helps show where Kevin O. Hicks may publish in the future.

Co-authorship network of co-authors of Kevin O. Hicks

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin O. Hicks. A scholar is included among the top collaborators of Kevin O. Hicks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin O. Hicks. Kevin O. Hicks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Emily, Amir Ashoorzadeh, Gib Bogle, et al.. (2022). Tissue Pharmacokinetic Properties and Bystander Potential of Hypoxia-Activated Prodrug CP-506 by Agent-Based Modelling. Frontiers in Pharmacology. 13. 803602–803602. 3 indexed citations

Mehta, Sunali, H.D. Sarath Liyanage, Ho H. Lee, et al.. (2021). Spatially-resolved pharmacokinetic/pharmacodynamic modelling of bystander effects of a nitrochloromethylbenzindoline hypoxia-activated prodrug. Cancer Chemotherapy and Pharmacology. 88(4). 673–687. 1 indexed citations

Hay, Michael P., et al.. (2019). Benzotriazine Di-Oxide Prodrugs for Exploiting Hypoxia and Low Extracellular pH in Tumors. Molecules. 24(14). 2524–2524. 4 indexed citations

Gu, Yongchuan, Jagdish K. Jaiswal, Jingli Wang, et al.. (2014). Photodegradation of the Benzotriazine 1,4-Di-N-Oxide Hypoxia-Activated Prodrug SN30000 in Aqueous Solution. Journal of Pharmaceutical Sciences. 103(11). 3464–3472. 6 indexed citations

Hay, Michael P., Kevin O. Hicks, & Jingli Wang. (2013). Hypoxia-Directed Drug Strategies to Target the Tumor Microenvironment. Advances in experimental medicine and biology. 772. 111–145. 19 indexed citations

Wang, Jingli, et al.. (2011). The 2-Nitroimidazole EF5 Is a Biomarker for Oxidoreductases That Activate the Bioreductive Prodrug CEN-209 under Hypoxia. Clinical Cancer Research. 18(6). 1684–1695. 55 indexed citations

Wang, Jie, et al.. (2011). EF5 as a predictive biomarker for activation of the new hypoxia-targeting prodrug SN30000.. Journal of Clinical Oncology. 29(15_suppl). e13597–e13597. 2 indexed citations

Hicks, Kevin O., Bronwyn G. Siim, Jagdish K. Jaiswal, et al.. (2010). Pharmacokinetic/Pharmacodynamic Modeling Identifies SN30000 and SN29751 as Tirapazamine Analogues with Improved Tissue Penetration and Hypoxic Cell Killing in Tumors. Clinical Cancer Research. 16(20). 4946–4957. 103 indexed citations

Hicks, Kevin O., Adam V. Patterson, Frederik B. Pruijn, et al.. (2007). Oxygen Dependence and Extravascular Transport of Hypoxia-Activated Prodrugs: Comparison of the Dinitrobenzamide Mustard PR-104A and Tirapazamine. International Journal of Radiation Oncology*Biology*Physics. 69(2). 560–571. 55 indexed citations

10.

Hay, Michael P., Frederik B. Pruijn, Kevin O. Hicks, et al.. (2007). Hypoxia-Selective 3-Alkyl 1,2,4-Benzotriazine 1,4-Dioxides: The Influence of Hydrogen Bond Donors on Extravascular Transport and Antitumor Activity. Journal of Medicinal Chemistry. 50(26). 6654–6664. 36 indexed citations

11.

Wilson, William R., Kevin O. Hicks, Susan M. Pullen, et al.. (2007). Bystander Effects of Bioreductive Drugs: Potential for Exploiting Pathological Tumor Hypoxia with Dinitrobenzamide Mustards. Radiation Research. 167(6). 625–636. 53 indexed citations

12.

Hay, Michael P., Kevin O. Hicks, Frederik B. Pruijn, et al.. (2006). 258 POSTER Tricyclic triazin 1,4-dioxides: a new class of hypoxia-selective cytotoxins with improved extravascular transport compared to tirapazamine. European Journal of Cancer Supplements. 4(12). 82–83. 1 indexed citations

13.

Patel, Kashyap, Yongchuan Gu, Kevin O. Hicks, et al.. (2006). 263 POSTER Metabolism and pharmacokinetics of PR-104, a hypoxia-activated nitrogen mustard prodrug in phase I clinical trial. European Journal of Cancer Supplements. 4(12). 84–84. 1 indexed citations

14.

Hicks, Kevin O., Frederik B. Pruijn, Timothy W. Secomb, et al.. (2006). Use of Three-Dimensional Tissue Cultures to Model Extravascular Transport and Predict In Vivo Activity of Hypoxia-Targeted Anticancer Drugs. JNCI Journal of the National Cancer Institute. 98(16). 1118–1128. 115 indexed citations

15.

Hicks, Kevin O., Kashyap Patel, Frederik B. Pruijn, Michael P. Hay, & William R. Wilson. (2005). Effect of cell type and drug lipophilicity on the extravascular transport of small molecule anticancer drugs: tirapazamine analogs. Cancer Research. 65. 969–969. 1 indexed citations

16.

Wilson, William R., Susan M. Pullen, Alison Hogg, et al.. (2004). In Vitro and In Vivo Models for Evaluation of GDEPT: Quantifying Bystander Killing in Cell Cultures and Tumors. Humana Press eBooks. 90. 403–432. 17 indexed citations

17.

Hicks, Kevin O., et al.. (2003). Multicellular resistance to tirapazamine is due to restricted extravascular transport: a pharmacokinetic/pharmacodynamic study in HT29 multicellular layer cultures.. PubMed. 63(18). 5970–7. 89 indexed citations

18.

Siim, Bronwyn G., et al.. (2000). Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs. Biochemical Pharmacology. 60(7). 969–978. 26 indexed citations

19.

Hicks, Kevin O., et al.. (1998). Extravascular diffusion of tirapazamine: effect of metabolic consumption assessed using the multicellular layer model. International Journal of Radiation Oncology*Biology*Physics. 42(3). 641–649. 77 indexed citations

20.

Hicks, Kevin O., et al.. (1960). Specificity of a transplantable tumor.. PubMed. 24. 193–202.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact